Marek Poszepcynski joined SV Health Investors in 2013, working as an equity analyst for International Biotechnology Trust plc.
His primary role is to analyse companies, with a particular focus on identifying potential M&A targets. Marek has more than 15 years of international experience in the life sciences industry with a focus on licensing and financing. He held management positions at Handelsbanken (2010-2012) as lead equity analyst, VP Business Development at Karolinska Development AB (2008-2010) and Licensing Director at Biovitrum AB (2002-2008. Marek has participated in two initial public offerings and a number of licensing and asset transfer transactions and received the Swedish Entrepreneurial Distinction 2015 through the founding, running and divesting of a profitable Contract Research Organisation.
Marek holds a MSc in Biochemistry and MSc in Business Management from the Royal Institute of Technology, Stockholm, Sweden.
- +44 (0) 20 7421 7079